Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $556.3100 (-1.97%) ($555.5400 - $576.0000) on Thu. Oct. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 31 | Latest Price | $556.3100(-1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(43%) SPLV(37%) IVW(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities). VIXM(-21%) TBT(-8%) VXX(-7%) UUP(-6%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $585.52 | 5 Day Moving Average | $574.34(-3.14%) | 10 Day Moving Average | $577.55(-3.68%) | 20 Day Moving Average | $585.52(-4.99%) | To recent high | -14% | To recent low | 2.2% | Market Cap | $58.985b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |